New implant for addiction treatment put to the test in healthy volunteers
Knowledge-focused
Recruiting now
This early-stage study is testing a new implantable pellet (BICX104) that slowly releases naltrexone over 3 months. Researchers want to see how the body processes the drug and if it's safe, comparing it to a standard monthly naltrexone shot. The study involves 30 healthy adults a…
Phase: PHASE1 • Sponsor: BioCorRx Pharmaceuticals Inc • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC